UBS Asset Management Americas Inc. raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,558,382 shares of the healthcare conglomerate’s stock after acquiring an additional 185,484 shares during the period. UnitedHealth Group comprises 0.8% of UBS Asset Management Americas Inc.’s holdings, making the stock its 14th biggest holding. UBS Asset Management Americas Inc. owned approximately 0.46% of UnitedHealth Group worth $845,215,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. lifted its stake in UnitedHealth Group by 1.2% in the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock valued at $12,873,786,000 after buying an additional 796,654 shares during the period. State Street Corp increased its holdings in shares of UnitedHealth Group by 2.5% during the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after acquiring an additional 1,122,534 shares in the last quarter. Alliancebernstein L.P. increased its holdings in shares of UnitedHealth Group by 2.3% during the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock valued at $1,466,104,000 after acquiring an additional 174,290 shares in the last quarter. TIAA CREF Investment Management LLC increased its holdings in shares of UnitedHealth Group by 3.9% during the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock valued at $1,090,720,000 after acquiring an additional 223,524 shares in the last quarter. Finally, Veritas Asset Management LLP increased its holdings in shares of UnitedHealth Group by 8.2% during the second quarter. Veritas Asset Management LLP now owns 5,291,867 shares of the healthcare conglomerate’s stock valued at $981,218,000 after acquiring an additional 399,878 shares in the last quarter. Institutional investors own 86.20% of the company’s stock.
UNH has been the subject of several recent research reports. Jefferies Group upped their price target on UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Friday, October 13th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a report on Thursday, September 21st. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Cantor Fitzgerald reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. Finally, Leerink Swann reaffirmed a “buy” rating and issued a $240.00 price target (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $224.56.
UnitedHealth Group Incorporated (UNH) traded down $1.33 during trading hours on Wednesday, reaching $220.09. The company’s stock had a trading volume of 3,246,300 shares, compared to its average volume of 3,119,193. UnitedHealth Group Incorporated has a twelve month low of $156.09 and a twelve month high of $231.77. The company has a market capitalization of $214,570.92, a price-to-earnings ratio of 23.07, a PEG ratio of 1.64 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the business earned $2.17 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. equities analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.26%.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 57,606 shares of company stock worth $11,566,525. Company insiders own 0.89% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://ledgergazette.com/2017/12/06/unitedhealth-group-incorporated-unh-shares-bought-by-ubs-asset-management-americas-inc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.